Back to mobile site

Amylin (AMLN) Reports Q3 Adj-Loss of $0.46, Misses by 4c

October 21, 2008 4:18 PM EDT Send to a Friend
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) reports a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login